Jason Mccoy
About Jason Mccoy
Jason McCoy is a Research Scientist I and II at the Broad Institute, where he focuses on discovering novel mitochondrial therapeutics. He has an extensive academic and professional background, including postdoctoral research at the University of Wisconsin-Madison and Weill Cornell Graduate School of Medical Sciences.
Current Role at Broad Institute
Jason Mccoy serves as a Research Scientist I and II at the Broad Institute of MIT and Harvard since 2015. In this role, he focuses on discovering novel mitochondrial therapeutics. His work involves developing and conducting screening assays that utilize cell-based systems, isolated mitochondria, and purified proteins. These assays aim to identify small molecule modulators of mitochondrial proteins, which are significant in the context of human disease.
Previous Experience in Research
Before joining the Broad Institute, Jason Mccoy held several research positions. He was a Postdoctoral Researcher at the University of Wisconsin-Madison from 2006 to 2008. Following this, he worked at Weill Cornell Graduate School of Medical Sciences as a Postdoctoral Researcher from 2008 to 2013. He then served as an Instructor at Baylor College of Medicine from 2013 to 2015. These roles contributed to his extensive experience in the field of biochemistry and molecular biology.
Educational Background
Jason Mccoy completed his Doctorate in Philosophy at the University of Wisconsin-Madison, where he studied Biochemistry and Philosophy from 2000 to 2006. Prior to that, he earned a Bachelor of Science degree in Biology and Chemistry from Truman State University between 1993 and 1997. His educational background provides a strong foundation for his research in mitochondrial therapeutics.
Early Career at Monsanto Company
Jason Mccoy began his professional career as a Process Development Scientist at Monsanto Company, where he worked from 1998 to 2000. This early experience in process development contributed to his understanding of scientific methodologies and applications in the biotechnology industry.